Correction : Scotiabank Downgrades Tempest Therapeutics to Sector Perform, Raises Price Target to $9 (Previous Target changed)

Benzinga · 04/10 12:27

Correction: Scotiabank analyst George Farmer downgrades Tempest Therapeutics (NASDAQ:TPST) from Sector Outperform to Sector Perform and raises the price target from $7 to $9. (Previous Target changed)